Leukostasis and hyperleukocytosis: Difference between revisions
Elcatracho (talk | contribs) |
|||
| (29 intermediate revisions by 9 users not shown) | |||
| Line 1: | Line 1: | ||
== Background | ==Background== | ||
*Hyperleukocytosis is lab abnormality of WBC >50-100K | |||
*Blood viscosity increases | |||
*Leukostasis is symptomatic hyperleukocytosis; it is a medical emergency | |||
**Most commonly seen with [[AML]] or [[CML]] in blast crisis | |||
**High blast cell count > WBC plugs in microvasculature | |||
***Brain and lung are most commonly affected | |||
*20-40% of patients with leukostasis die within 1st week of presentation | |||
* | ==Clinical Features== | ||
* | *[[Fever]] | ||
* | **80% of patients | ||
* | **May be due to inflammation associated with leukostasis or concurrent infection | ||
* | *Brain Leukostasis | ||
* | **[[Headache]] | ||
**[[Dizziness]] | |||
**[[Tinnitus]] | |||
**[[Visual disturbances]] | |||
**[[Ataxia]] | |||
**[[Confusion]] | |||
**Stupor | |||
**[[Coma]] | |||
**Sudden death | |||
*Pulmonary Leukostasis | |||
**[[Respiratory distress]] | |||
**[[Hypoxemia]] | |||
***[[ABG]] may show falsely decreased PaO2; pulse oximetry is more accurate | |||
**[[Respiratory failure]] | |||
==Differential Diagnosis== | |||
{{Oncologic emergencies DDX}} | |||
* | ==Evaluation== | ||
** | ===Work-Up=== | ||
** | *CBC | ||
** | *DIC labs | ||
**[[DIC]] occurs in up to 40% of patients | |||
**FDP, d-dimer, fibrinogen, coags | |||
*[[Tumor Lysis Syndrome]] labs | |||
**TLS occurs in up to 10% of patients | |||
**Chemistry | |||
**Uric acid | |||
**Calcium | |||
**Phosphate | |||
== | ===Evaluation=== | ||
*High degree of suspicion to make diagnosis | *High degree of suspicion needed to make the diagnosis | ||
*WBC count | *WBC count usually >100K; can have symptoms with WBC as low as 50K | ||
*CXR | *[[CXR]] | ||
**Interstial or alveolar infiltrates | |||
== | ==Management== | ||
*IV hydration | *Hyperleukocytosis (asymptomatic) | ||
* | **[[Hydroxyurea]] may be all that is required | ||
* | *Leukostasis | ||
* | **IV hydration | ||
***Prevent dehydration which can worsen condition | |||
**Chemotherapy | |||
***Only treatment proven to improve survival | |||
**[[Hydroxyurea]] + leukapheresis | |||
***Can be use for cytoreduction if chemo will be delayed | |||
*[[Allopurinol]] may help prevent [[Tumor lysis syndrome]] | |||
*Consider [[rasburicase]] | |||
*Broad spectrum [[antibiotics]] | |||
**The leading cause of death in blast crisis is infection (patients are functionally [[neutropenia|neutropenic]]) | |||
== Disposition | ==Disposition== | ||
*Admit to ICU | *Admit to ICU | ||
== | ==References== | ||
<references/> | |||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Latest revision as of 02:32, 11 January 2022
Background
- Hyperleukocytosis is lab abnormality of WBC >50-100K
- Blood viscosity increases
- Leukostasis is symptomatic hyperleukocytosis; it is a medical emergency
- 20-40% of patients with leukostasis die within 1st week of presentation
Clinical Features
- Fever
- 80% of patients
- May be due to inflammation associated with leukostasis or concurrent infection
- Brain Leukostasis
- Pulmonary Leukostasis
- Respiratory distress
- Hypoxemia
- ABG may show falsely decreased PaO2; pulse oximetry is more accurate
- Respiratory failure
Differential Diagnosis
Oncologic Emergencies
Related to Local Tumor Effects
- Malignant airway obstruction
- Bone metastases and pathologic fractures
- Malignant spinal cord compression
- Malignant Pericardial Effusion and Tamponade
- Superior vena cava syndrome
Related to Biochemical Derangement
- Hypercalcemia of malignancy
- Hyponatremia due to SIADH
- Adrenal insufficiency
- Tumor lysis syndrome
- Carcinoid syndrome
Related to Hematologic Derangement
Related to Therapy
- Chemotherapy-induced nausea and vomiting
- Cytokine release syndrome
- Chemotherapeutic drug extravasation
- Differentiation syndrome (retinoic acid syndrome) in APML
- Stem cell transplant complications
- Catheter-related complications
- Tunnel infection
- Exit site infection
- CVC obstruction (intraluminal or catheter tip thrombosis)
- Catheter-related venous thrombosis
- Fracture of catheter lumen
- Oncologic therapy related adverse events
Evaluation
Work-Up
- CBC
- DIC labs
- DIC occurs in up to 40% of patients
- FDP, d-dimer, fibrinogen, coags
- Tumor Lysis Syndrome labs
- TLS occurs in up to 10% of patients
- Chemistry
- Uric acid
- Calcium
- Phosphate
Evaluation
- High degree of suspicion needed to make the diagnosis
- WBC count usually >100K; can have symptoms with WBC as low as 50K
- CXR
- Interstial or alveolar infiltrates
Management
- Hyperleukocytosis (asymptomatic)
- Hydroxyurea may be all that is required
- Leukostasis
- IV hydration
- Prevent dehydration which can worsen condition
- Chemotherapy
- Only treatment proven to improve survival
- Hydroxyurea + leukapheresis
- Can be use for cytoreduction if chemo will be delayed
- IV hydration
- Allopurinol may help prevent Tumor lysis syndrome
- Consider rasburicase
- Broad spectrum antibiotics
- The leading cause of death in blast crisis is infection (patients are functionally neutropenic)
Disposition
- Admit to ICU
